Logista signs pharma deal while Logista stock trades below its high

Published on 10/08/2026 at 15:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Logista signed a Pharma agreement on September 9, 2026 for Grafalon distribution in Spain. Logista stock costs EUR 34.77 after EUR 34.52.

Logista, ES0105027009, Illustration mit AI erstellt.

Logista (ES0105027009) had signed a strategic agreement with Neovii on September 9, 2026 to distribute Grafalon in Spain, while Logista stock was at EUR 34.77 at Lang & Schwarz on October 8, 2026, up 0.72 percent from EUR 34.52. The agreement gives Logista Pharma responsibility for procurement, storage, hospital distribution and invoicing for the transplant medicine.

Cold-chain service adds operational depth

According to Logista on September 9, 2026, Grafalon must remain between 2 and 8 degrees Celsius throughout the logistics process. Logista Pharma will use specialized facilities, monitoring systems and Nacex deliveries to maintain traceability from warehouse to hospital.

The value of the agreement is operational rather than disclosed in euros: it expands Logista's role from transport into a 360-degree service covering the full supply chain. That matters because temperature-controlled handling creates a higher service requirement than standard distribution, although the release gives no revenue or profit contribution for the contract.

Three dated company developments

On July 29, 2026, Logista Parcel had invested EUR 6.00 million during the year to strengthen cold-chain capabilities, according to MarketScreener. On September 9, 2026, the company signed the Grafalon agreement, with storage required at 2 to 8 degrees Celsius, according to Logista. On October 1, 2026, NACEX by Logista expanded a cancer-prevention collaboration linked to a circuit that began with a race on September 19, according to Corresponsables.

What does the agreement mean for margins?

The latest contract does not provide a margin target, but Logista's broader 2025 figures show the economics investors are measuring. The company reported EUR 1.809 billion in economic sales, EUR 378 million in adjusted EBIT and EUR 281 million in net profit for fiscal 2025 on its company website. Its net profit was therefore 15.6 percent below adjusted EBIT, a comparison that highlights the importance of service costs, taxes and other items between operating profit and the bottom line.

Stock remains below its yearly high

Logista stock was 7.92 percent below its 52-week high of EUR 37.76 on October 8, 2026, based on the Lang & Schwarz price of EUR 34.77. The same session's market capitalization was EUR 4.6 billion, while the primary listing is BME under ticker LOG and the company operates in integrated freight and logistics.

The further course of trading is shown by the continuously updated real-time quote of Logista stock.